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Developing new therapeutic approaches to treat acute
kidney injury requires a detailed understanding of
endogenous cellular repair. Genetic fate mapping defines
cellular hierarchies in vivo and we used this technique to
assess a possible contribution of non-epithelial stem cells to
renal repair after ischemic injury. Mice with efficient labeling
of renal epithelial cells, but not non-epithelial interstitial cells,
were subjected to a single cycle or sequential cycles of kidney
injury and repair. No dilution of the epithelial cell fate marker
was observed despite robust epithelial cell proliferation.
Thus, non-tubular cells do not have the ability to migrate
across the basement membrane and differentiate into
epithelial cells in this model. Instead, surviving tubular
epithelial cells are responsible for repair of the damaged
nephron. Future studies will need to distinguish between
uniform dedifferentiation and proliferation of all epithelial
cells after injury versus selective expansion of an intratubular
epithelial stem cell.
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KIDNEY REPAIR AND INTERSTITIAL STEM CELLS
Acute kidney injury (AKI) is common, costly, and indepen-
dently associated with increased risk of death.1 Patient
outcomes are directly related to AKI severity, including what
are considered minor changes in serum creatinine.2 More
severe AKI is an independent risk factor for death, and the
modest improvement in mortality observed in recent years
is offset by the increasing prevalence of AKI in our aging
population.3 Novel directed therapies are needed for the
treatment of AKI, and stem cells have generated a
tremendous amount of excitement because of their potential
to lead to new treatment approaches. Tissue-specific adult
stem cells have important roles in early development, as well
as in tissue homeostasis and regeneration in the hemato-
poietic system, skin, intestine, and muscle. However, the
existence of epithelial stem cells in the kidney is still
controversial.4–6
Adult renal stem cells could have important therapeutic
uses.7–11 For example, manipulating the signaling pathways
that regulate growth and differentiation of renal progenitors
might enhance repair after AKI. Renal stem cells might serve
as a cellular source for preclinical toxicity testing or to seed
the bioartificial kidney, a hemofiltration system containing
live human tubular epithelial cells.12,13 Mesenchymal stem
cells (MSCs) ameliorate AKI by paracrine mechanisms14
and they are currently being tested in a Phase 1 trial.15 As
accumulating evidence implicates an episode of AKI in the
development of chronic kidney disease, stem cell therapies for
AKI may provide long-term benefits as well.16 Finally, the
isolation of renal stem cells from human kidney biopsy
specimens could enable the creation of disease-specific
models for research. A necessary first step for many of these
applications, however, is definitive proof that such cells exist
in the adult kidney to allow isolation, as well as phenotypic
and functional characterization of such cells. Progress toward
achieving these goals has been slow in the kidney because of
the complexity of the tissue architecture and a lack of stem
cell markers.
Several lines of evidence have supported the existence of a
non-tubular, interstitial stem cell population in kidney.
During nephrogenesis, the cells that make up nephron
epithelia, including podocytes and tubule segment epithelia,
are derived from a common progenitor that also gives rise to
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the interstitial cell types, such as pericytes or perivascular
fibroblasts and mesangium. These progenitors are present in
metanephric mesenchyme, a prespecified group of cells that is
induced toward kidney fates by inductive signals secreted by
the ureteric bud. As interstitial and tubular cells share a
common mesenchymal progenitor, persistence of a small
number of these mesenchymal cells in the adult interstitium
could serve as a stem cell niche for tubule regeneration after
injury. Indeed, in lower vertebrates such as the adult skate
(Leucoraja erinacea), the zebrafish (Danio rerio), and the
goldfish (Carassius auratus), for example, partial nephrec-
tomy or nephrotoxic damage induces de novo nephrogenesis
in a process recapitulating embryonic kidney development,
including condensation of interstitial mesenchyme-like
cells.17–19 In mammals, certain interstitial populations express
stem cell markers such as Sca-1,20,21 CD34 and CD44,22
CD133,23 or long-term label retention,24 and in some cases
these cells appear to engraft into endogenous tubular
epithelium when injected during nephrogenesis or after
kidney injury.
LINEAGE ANALYSIS TO DEFINE EPITHELIAL CELL ORIGINS
To definitively test whether an endogenous interstitial stem
cell population might contribute to the epithelial lineage
during mammalian renal repair, all mesenchyme-derived
renal epithelial cells were genetically labeled using a Cre/Lox
strategy. The Six2 gene is expressed exclusively in metaneph-
ric mesenchyme cells fated to become renal epithelia,25 and
we crossed a transgenic mouse in which the Six2 promoter
drives expression of a green fluorescence protein (GFP)–Cre
recombinase fusion protein (the Six2-GC mouse) against two
different reporter mice, the Rosa26-LacZ (R26R) reporter
and the ACTB-Bgeo,-DsRed.MST reporter (Z/Red). Because
the Six2 gene is active very early in nephrogenesis,
recombination efficiency is high and we achieved 95%
labeling of all tubular epithelial cells derived from the
metanephric mesenchyme (collecting duct epithelia are
derived from the ureteric bud, and therefore not labeled in
this model).26 The rationale is outlined in Figure 1. As
interstitial cells are not labeled, after a cycle of injury and
repair, dilution of the fate marker would indicate contribu-
tion to the epithelial lineage by unlabeled interstitial cells. If
repaired tubules still express the fate marker, by contrast, then
repairing epithelial cells originated from within the tubule.
Close inspection of kidney sections confirmed that no
interstitial cells were labeled, either with b-galactosidase
(LacZ) or with red fluorescent protein (RFP). GFPCre fusion
protein expression was undetectable after the completion of
nephrogenesis (P3-5), whether assessed by epifluorescence or
antibody-based detection of GFP (the GFPCre fusion protein
retains GFP fluorescence), Six2 mRNA, or Six2 protein using
a specific antisera (as GFPCre expression is regulated by the
Six2 promoter, the GFP expression pattern mirrors expres-
sion of endogenous Six2 mRNA and protein). Mice were
subjected to renal ischemia/reperfusion injury to trigger the
proliferative response. Two days after injury, 47.4% of cells in
the outer medulla expressed the proliferation marker Ki67,
and these cells coexpressed RFP. Many tubules had flattened
epithelial cells characteristic of the dedifferentiated state, and
these cells also expressed either RFP or LacZ. When mice
were injured and given an injection of 5-bromo-20-deoxy-
uridine once daily for 7 days, 66.9% of outer medulla
epithelial cells had incorporated 5-bromo-20-deoxyuridine,
compared with 3.5% in uninjured, control kidneys. Despite
this robust proliferation, there was no dilution of the fate marker
in kidneys that had been allowed to repair for 15 days. A total of
94.3±3.7% of outer medullary epithelia were RFP positive
before injury, and 94.4±2.4% expressed RFP after repair with
similar results calculated for LacZ as the fate marker.26
If the GFPCre fusion protein were re-expressed in
epithelial cells after injury, then a non-labeled interstitial cell
that had migrated into the damaged tubule might also be
induced to express GFPCre, and thus activate expression of
either RFP or LacZ, compromising our ability to detect a
dilution of the fate marker. However, we did not detect re-
expression of the transgene, as assessed by sensitive GFP
immunofluorescence despite very robust GFP fluorescence in
the cap mesenchyme of P1 kidneys from Six2-GC mice, a
stage at which Six2 is still expressed. We were also unable to
detect Cre mRNA after injury by qualitative reverse
transcriptase-polymerase chain reaction, and we did not
detect endogenous Six2 protein in adult kidney after injury
using a specific anti-Six2 antibody.
To verify these results, we also performed the converse
experiment by labeling interstitial but not epithelial cells,
using a FoxD1-Cre driver. In this case, the interstitial
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Figure 1 | Lineage tracing to determine origin of epithelial
cells after kidney repair. Genetically labeled tubule cells are dark
gray, and interstitial cells are unlabeled. After injury, there is
necrosis and apoptosis of labeled epithelial cells. If tubule repair
involves an interstitial stem cell, these unlabeled cells will dilute
the genetic marker and tubules will lose the label after
completion of repair (model 1). If surviving epithelial cells
are responsible for tubule repair, then the genetic marker will
not be diluted by unlabeled cells after completion of repair
(model 2).
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compartment, including pericytes, fibroblasts, and mesan-
gium, was efficiently labeled. After a cycle of injury and
repair, there was no increase in labeled epithelial cells in the
tubule, providing further strong evidence against the
possibility that an interstitial cell population is capable of
contributing to the epithelial lineage during endogenous
repair.
UNRESOLVED QUESTIONS
If surviving epithelial cells are responsible for tubule
repair, how can this be reconciled with the notion that renal
interstitium contains a stem cell population with multi-
lineage differentiation capability—cells that also ameliorate
ischemic renal injury when administered exogen-
ously?20,21,23,24,27,28 An intriguing hypothesis has been
proposed that these interstitial cell populations are all MSCs
derived from the perivascular niche.20,29,30 Indeed, pericytes
themselves—mesenchymal-like cells associated with the walls
of small blood vessels directly adjacent to endothelial cells—
may directly give rise to MSCs.31 These cells are poised to
respond to vascular injury and integrate injury signals from
the vasculature to regulate epithelial repair and modulate the
immune response. Through secretion of bioactive molecules
that exert antiapoptotic and proproliferative effects on
tubular epithelial cells, as well as immunomodulatory actions
on migrating inflammatory cells, these adult kidney-specific
MSCs could function in a paracrine manner to promote
tissue repair.14 The ability of exogenous, bone marrow-
derived MSCs to protect against kidney injury through
secretion of soluble mediators suggests that endogenous,
organ-specific MSCs in renal perivasculature may also
function on tubular cells in a similar paracrine manner.32,33
Whether nestin-positive, interstitial slow cycling cells in renal
papilla might represent such a population of kidney-specific
MSCs requires investigation.24,26
Another unresolved question is whether an intratubular
epithelial stem cell might exist, or whether every epithelial
cell has the equivalent capacity to dedifferentiate and
proliferate after injury. In support of an intratubular stem
cell, stem cell markers including Oct4 and label retention
have been used to derive cell lines with stem cell proper-
ties.28,34 In Drosophila, an intratubular pluripotent has been
definitively identified, bolstering the contention that a
mammalian equivalent might exist.35 Arguing against an
intratubular stem cell is the rapidity of the epithelial
proliferative response to injury and the failure to detect
phenotypic differences between quiescent and dividing
epithelial cells during kidney homeostasis.36,37 An intriguing
recent study by Vogetseder and colleagues38 in rat, using a
lead acetate mitotic stimulus, suggested that B40% of
proximal tubules express cyclin D1, indicating that they are
in G1 rather than G0, and this proportion falls after the
proliferative stimulus suggesting progression through the cell
cycle. As cyclin D1 helps regulate cell cycle re-entry, one
interpretation of this observation is that the capacity to
divide is not restricted to a small subset of proximal tubule
epithelia, as would be expected for an intratubular stem cell
model. It will be important to re-address this conclusion
using a model that induces tubule injury including epithelial
dedifferentiation, such as renal ischemia.
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